Gemini Vitamin D Analog Suppresses ErbB2-Positive Mammary Tumor Growth via Inhibition of ErbB2/AKT/ERK Signaling

Documenti analoghi

• Oral administration of a Gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression
  di: So, Jae Young, et al.
  Pubblicazione: (2013)
• Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
  di: Jae Young So, et al.
  Pubblicazione: (2013-01-01)
• Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer
  di: So, Jae Young, et al.
  Pubblicazione: (2013)
• Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog
  di: Wahler, Joseph, et al.
  Pubblicazione: (2014)
• Gemini Vitamin D Analogs Inhibit Estrogen Receptor Positive and Estrogen Receptor Negative Mammary Tumorigenesis without Hypercalcemic Toxicity
  di: Lee, Hong Jin, et al.
  Pubblicazione: (2008)